Evidence-based medicine

Research: Surgeons, Hospitals Involved in Exceptional Research Have Lower Patient Mortality Rates, Fewer Complications

Retrieved on: 
星期三, 四月 3, 2024
Software, Research, Oncology, Technology, Hospitals, Health Technology, Science, Surgery, Cardiology, Neurology, Practice Management, Health, JAMA, Evidence-based medicine, Surgeon, Urology, Environment, Physician, Impact factor, Hospital, Mortality, Patient, General surgery, Neurosurgery, Ear, Woman, Otorhinolaryngology, Male, Publication, Novant Health, Harvard Business Review, Nose, Surgical oncology, Medicare, PubMed, Elective surgery, Gastroenterology

Surgeons and hospitals who conduct the most leading-edge research achieve lower rates of patient mortality and complications than those who do not, according to findings released today by Avant-garde Health.

Key Points: 
  • Surgeons and hospitals who conduct the most leading-edge research achieve lower rates of patient mortality and complications than those who do not, according to findings released today by Avant-garde Health.
  • Patients under the care of top surgeon-researchers showed a 5% lower rate of post-discharge complications and a 5% lower rate of mortality, within 30 days post-discharge, according to the research.
  • All 4,500 physicians and 350 hospitals being honored are listed on the Research All-Stars site .
  • In addition, a significant portion of the top surgeon-researchers – 47.1% on average – served as the leading or senior authors of their research.

USA Patient Registry Software Market Outlook to 2028, Featuring IQVIA, Optum (UnitedHealth Group), Phytel, Dacima Software, FIGmd, Syapse and Pharos Innovations - ResearchAndMarkets.com

Retrieved on: 
星期二, 三月 19, 2024
Oncology, Research, Software, University, Infectious Diseases, Education, Hospitals, Health Technology, Genetics, Health Insurance, Data Management, Science, Technology, Clinical Trials, Biotechnology, FDA, Insurance, Health, Professional Services, IOT (Internet of Things), Data Analytics, White House, Federal Government, Practice Management, Managed Care, Other Health, Public Policy, Government, Pharmaceutical, Other Science, Pancreatic disease, Consolidated, Patient, Conditional sentence, Optum, Health information management, Food and Drug Administration, Geography, NPF, RWE, Internet of things, Openclinica, DNA, Policy, Electronic health record, NIH, City, Privacy, CMS, Food, Organization, Prevalence, Federation, Internet, Cancer, Drug development, IQVIA, Evidence-based medicine, RDCRN, Type, Data science, Caregiver, Public health surveillance, Government agency, Registry, EHR, CDC, National Institutes of Health, Bangladesh Technical Education Board, Medicare, Collection, Medical device

The patient registry market in the US involves the collection, management & analysis of data related to patients with specific medical conditions & diseases.

Key Points: 
  • The patient registry market in the US involves the collection, management & analysis of data related to patients with specific medical conditions & diseases.
  • Patient registry software could facilitate data sharing and analysis among these entities, leading to increased adoption
    The patient registry software market in the USA is a part of the broader healthcare information technology sector.
  • Key players in the USA patient registry software market includes IQVIA, Dacima Software, OpenClinica, FIGmd, Dendrite Clinical Systems and various universities conducting medical clinical studies.
  • As technology & data science continue to evolve, the patient registry software market is likely to incorporate more advanced analytics techniques.

The Medical University of South Carolina and Flatiron Health Announce Collaboration to Drive More Standardized, Efficient, and Effective Cancer Care

Retrieved on: 
星期三, 三月 13, 2024
Research, Technology, Clinical Trials, Health Technology, University, Health, Science, Education, Oncology, Artificial Intelligence, Evidence-based medicine, Associate, Patient, NCCN, Assist, MD, MHS, Medical school, Flatiron, MUSC, Division, Clinical Oncology, Hematology, Medicine, Nursing

The collaboration between Flatiron Health and MUSC will equip clinicians with advanced cancer care insights from Flatiron Assist, an oncology-specific clinical decision support platform that prioritizes the latest evidence-based medicine, site-preferred pathways, and clinical research at the point of care.

Key Points: 
  • The collaboration between Flatiron Health and MUSC will equip clinicians with advanced cancer care insights from Flatiron Assist, an oncology-specific clinical decision support platform that prioritizes the latest evidence-based medicine, site-preferred pathways, and clinical research at the point of care.
  • “Partnering with the Medical University of South Carolina’s Hollings Cancer Center, a market-leading cancer care provider, is an incredible opportunity to accelerate our shared vision for the delivery of more standardized, efficient, and effective cancer care,” said James Hamrick, MD, Vice President of Clinical Oncology at Flatiron Health.
  • Flatiron Assist users also adopt novel therapies an average of 59 days sooner than non-Flatiron Assist users ensuring higher quality care.
  • “This project will reduce variability in cancer treatment while increasing the quality of cancer care provided across the state of South Carolina.”

OncoHost Wins 2024 Artificial Intelligence Excellence Award

Retrieved on: 
星期三, 三月 20, 2024
Overfitting, Evidence-based medicine, Progression-free survival, Physician, Patient, Cancer, MD, Protein, Medicine, Clinical trial, Therapy, Machine learning, Probability, Artificial intelligence, Pharmaceutical industry

PHILADELPHIA, BINYAMINA, Israel and CARY, N.C., March 20, 2024 /PRNewswire/ -- The Business Intelligence Group today announced that OncoHost, a technology company transforming the approach to precision medicine for improved patient outcomes, has been named a winner in its Artificial Intelligence Excellence Awards program in the category of machine learning.

Key Points: 
  • PHILADELPHIA, BINYAMINA, Israel and CARY, N.C., March 20, 2024 /PRNewswire/ -- The Business Intelligence Group today announced that OncoHost , a technology company transforming the approach to precision medicine for improved patient outcomes, has been named a winner in its Artificial Intelligence Excellence Awards program in the category of machine learning.
  • "We are truly honored to recognize OncoHost with this prestigious award," stated Maria Jimenez, Chief Nominations Officer for the Business Intelligence Group.
  • "The unwavering commitment of their team to excellence and their innovative AI applications have catapulted them to this remarkable achievement.
  • "We are honored to receive the AI Excellence Award, which recognizes our commitment to advancing precision medicine through innovative machine learning applications," said Ofer Sharon, MD, CEO of OncoHost.

Sorcero Named to Fast Company's Annual List of the World's Most Innovative Companies of 2024, #1 in Small & Mighty Category

Retrieved on: 
星期二, 三月 19, 2024
Culture, Evidence-based medicine, Science, Health, Patient, Small, AI, Quality of life, Gemini, Medical device

WASHINGTON, March 19, 2024 /PRNewswire-PRWeb/ -- Sorcero, the transformative AI platform for life sciences, has been named to Fast Company's prestigious list of the World's Most Innovative Companies of 2024, as No. 1 in the Small and Mighty Category. The list recognizes businesses that profoundly impact industry and culture through innovation.

Key Points: 
  • WASHINGTON, March 19, 2024 /PRNewswire-PRWeb/ -- Sorcero, the transformative AI platform for life sciences, has been named to Fast Company's prestigious list of the World's Most Innovative Companies of 2024, as No.
  • "We're thrilled to be recognized by Fast Company for our work in revolutionizing patient care with AI," said Dipanwita Das, CEO and Co-founder of Sorcero.
  • "We're thrilled to be recognized by Fast Company for our work in revolutionizing patient care with AI," said Dipanwita Das, CEO and Co-founder of Sorcero.
  • Sorcero PLS unlocks the science behind treatments and empowers patients to actively participate in their health journeys.

New York's PSS to Recognize Trailblazing Geriatrician Dr. Rosanne Leipzig, NYC's Department for the Aging and CaringKind at Annual Awards Presentation, May 9

Retrieved on: 
星期二, 三月 12, 2024
Internal medicine, PSS, Quality of life, PSA, Dementia, Ageing, AmeriCorps Seniors, Second, Commissioner, Johns Hopkins University Press, Evidence-based medicine, Partnership, Mental health, Ageism, American College, Safety, Workforce, Medicine, Public key certificate, Alzheimer's disease, Performing arts of Australia, Gray Panthers, Public policy, Research, Fifth Avenue Presbyterian Church, Mentorship, New Yorker, Retirement, Family, Hospice, Award, Doctor of Philosophy, Life, Palliative care, Multimedia, Physician, Nursing

NEW YORK , March 12, 2024 /PRNewswire/ -- PSS (www.pssusa.org), a multi-service nonprofit agency that has served older New Yorkers and their families for more than 60 years, today named three champions in the field of aging whose work will be celebrated at its annual PSS Honors event at Fifth Avenue Presbyterian Church in Manhattan on Thursday evening, May 9:

Key Points: 
  • The eighth annual Circle of Care Award, for excellence in dementia treatment, salutes CaringKind for breaking new ground in Alzheimer's caregiving.
  • The organization partners with PSS's Circle of Care program, which provides assistance and respite to family caregivers.
  • CaringKind President and CEO Eleonora Tornatore-Mikesh will accept on behalf of the agency.
  • The award stems from the PSS "Coming of Age" program, which inspires people 50 and older to live with passion and purpose.

Apyx Medical Corporation Announces Renuvion to be Featured in Educational Sessions at the American Academy of Cosmetic Surgery (AACS) Scientific Meeting

Retrieved on: 
星期三, 二月 21, 2024
Health, General Health, Transfer, Abdominoplasty, Skin, Patient, Adjuncts, Medicine, MD, Still Over It, MBA, Evidence-based medicine, AACS, Safety, Pitfalls, Elective surgery, Plasma, Cosmetic, American Academy

Apyx Medical Corporation (Nasdaq: APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announced that its Renuvion technology will be featured in three educational sessions at the upcoming American Academy of Cosmetic Surgery’s 40th Annual Scientific Meeting, to be held in New Orleans, LA from February 22 – 24.

Key Points: 
  • Apyx Medical Corporation (Nasdaq: APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announced that its Renuvion technology will be featured in three educational sessions at the upcoming American Academy of Cosmetic Surgery’s 40th Annual Scientific Meeting, to be held in New Orleans, LA from February 22 – 24.
  • “Apyx Medical is pleased to see Renuvion featured in a variety of insightful educational presentations during AACS 2024, which we believe will help to expand the awareness of our Helium Plasma Technology and its benefits,” said Charlie Goodwin, President and Chief Executive Officer of Apyx Medical.
  • Demographic, procedure and safety data were collected and evaluated from a contiguous series of more than 450 patients, including 229 patients treated with Renuvion and 236 patients treated with Bipolar RF.
  • The researchers analyzed adverse events recorded by the body area during or post-procedure for each group.

Patient Safety Movement Foundation’s Mid-Year Meeting Charts Course for Global Patient Safety Initiatives in 2024

Retrieved on: 
星期六, 一月 27, 2024
Nursing, Public Policy, Government, Health, Healthcare Reform, Hospitals, Health Insurance, General Health, Momentum, Patient safety, World Health Organization, Patient, Hospital, Cause of action, Open data, Evidence-based medicine, Multimedia, ApiJect Systems, Summit, Competition, University, Algorithm, Johns Hopkins, PCAST, PSMF, Safety, Public health, ZERO, Approximation error

The Patient Safety Movement Foundation (PSMF) convened its annual Mid-Year Event to discuss safety challenges in the healthcare system that result in millions of preventable deaths around the world.

Key Points: 
  • The Patient Safety Movement Foundation (PSMF) convened its annual Mid-Year Event to discuss safety challenges in the healthcare system that result in millions of preventable deaths around the world.
  • View the full release here: https://www.businesswire.com/news/home/20240126619652/en/
    Patient Safety Movement Foundation Founder Joe Kiani speaks about the road ahead in global efforts to eliminate preventable patient harm at the PSMF's annual Mid-Year Event.
  • In 2012, Joe Kiani founded the non-profit Patient Safety Movement Foundation (PSMF) to eliminate preventable medical errors in hospitals.
  • His team worked with patient safety experts from around the world to create Actionable Evidence-Based Practices (AEBP) that address the top challenges.

Family Physicians Inquiries Network Appoints New President

Retrieved on: 
星期三, 一月 24, 2024
Family medicine, Associate, Evidence-based medicine, MD, Health equity, Faculty, University, Weill Cornell Medicine, Committee on Finance, Executive director, Organization, Literature, Inclusion, Preventive healthcare, Management

COLUMBIA, Mo., Jan. 24, 2024 /PRNewswire/ -- José Rodríguez, MD, a family physician in Salt Lake City, has been appointed President of the Family Physicians Inquiries Network.

Key Points: 
  • COLUMBIA, Mo., Jan. 24, 2024 /PRNewswire/ -- José Rodríguez, MD, a family physician in Salt Lake City, has been appointed President of the Family Physicians Inquiries Network.
  • He will serve as an ambassador for the organization, connecting with other Family Medicine organizations, developing Board liaisons, and participating in other organizations' board committees as appropriate.
  • "I have always been grateful to FPIN for giving me the tools and the early wins I needed to launch a career in academic family medicine," said Rodríguez.
  • José Rodríguez completed medical school at Weill Cornell Medical College and his family medicine residency at Albert Einstein College of Medicine.

First Patient Enrolled in Merit Medical’s MOTION Study

Retrieved on: 
星期二, 一月 16, 2024
Injection, IDE, Osteoarthritis, Patient, Risk, Hypervascularity, Evidence-based medicine, MD, Knee, Incidence, Microparticle, FDA, Pain, Inflammation, Blood, MMSI, GAE, Prevalence, Pharmaceutical industry

Under this designation, Embosphere Microspheres received priority review by the FDA, which allowed for accelerated review and development of the MOTION study protocol.

Key Points: 
  • Under this designation, Embosphere Microspheres received priority review by the FDA, which allowed for accelerated review and development of the MOTION study protocol.
  • In conducting the study, Merit intends to randomize patients 1:1 to receive either GAE using Embosphere Microspheres or intra-articular corticosteroid injections.
  • The study is structured to evaluate primary safety and effectiveness of Embosphere Microspheres at 6 months with continued patient follow up through 24 months.
  • “The commencement of this randomized controlled study is a testament to our commitment to evidence-based medicine and patient-centric care,” said Sandeep Bagla, MD, Co-Global Principal Investigator of the MOTION study.